XML 63 R31.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule Of Effective Income Tax Rate Reconciliation

The Company’s effective tax rates for the years ended December 31, 2021 and 2020 differ from the U.S. federal statutory rate as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2021

 

 

2020

 

Tax at the federal statutory rate

 

$

(18,790

)

 

$

(6,919

)

Benefit from R&D tax credits

 

 

(1,244

)

 

 

(586

)

Stock-based compensation

 

 

1,102

 

 

 

331

 

Non-deductible executive compensation

 

 

817

 

 

 

 

Other temporary and permanent differences

 

 

33

 

 

 

21

 

Change in valuation allowance

 

 

18,082

 

 

 

7,153

 

Total provision for income taxes

 

$

 

 

$

 

Schedule Of Deferred Tax Assets And Liabilities

The significant components of the Company’s deferred tax assets and liabilities were as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2021

 

 

2020

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforward

 

 

33,671

 

 

 

18,832

 

Lease liability

 

 

1,228

 

 

 

677

 

R&D tax credit carryforward

 

 

2,746

 

 

 

1,502

 

Share-based compensation

 

 

2,151

 

 

 

227

 

Other deferred tax assets

 

 

237

 

 

 

109

 

Total deferred tax assets

 

 

40,033

 

 

 

21,347

 

Deferred tax liabilities - Right of use asset

 

 

(994

)

 

 

(458

)

Valuation allowance

 

 

(39,039

)

 

 

(20,889

)

Net deferred tax assets

 

$

 

 

$